Literature DB >> 11863129

Is continuous veno-venous hemofiltration for acetaminophen-induced acute liver and renal failure worthwhile?

R Agarwal1, M O Farber.   

Abstract

We describe a patient with acute liver and renal failure secondary to acetaminophen and chronic alcohol abuse who was treated aggressively with oral acetylcysteine, continuous renal replacement therapy, glucose and branched-chain amino acid intravenous feeding and ventilatory support. The patient had a predicted mortality of > 95% without liver transplantation however, with intensive ventilatory, renal, and nutritional support he made a complete recovery. We discuss the benefits of aggressive supportive therapy and suggest that continuous renal replacement therapy may allow gentle fluid removal, excellent control of cerebral edema and intravenous feeding that may favorably influence prognosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863129     DOI: 10.5414/cnp57167

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

Review 1.  Liver support systems: will they ever reach prime time?

Authors:  Rafael Bañares; María-Vega Catalina; Javier Vaquero
Journal:  Curr Gastroenterol Rep       Date:  2013-03

Review 2.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

3.  Acetaminophen clearance during ex vivo continuous renal replacement therapies.

Authors:  Bridget A Scoville; Vera Vulaj; Bruce A Mueller; Gail M Annich; Deborah S Wagner
Journal:  J Artif Organs       Date:  2017-10-23       Impact factor: 1.731

4.  Continuous Venovenous Hemofiltration as a Rescue Therapy for Severe Acetaminophen Toxicity in a Toddler.

Authors:  Puspraj Awasthi; Ankush Jindal; Yogish Sharma; Vijai Williams; Namita Ravikumar; Karthi Nallasamy; Suresh Kumar Angurana
Journal:  J Pediatr Intensive Care       Date:  2020-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.